US Archives - Page 181 of 215 - European Medical Journal

Steroid-Induced Hyperglycemia in Rheumatoid Arthritis: A Case Report

Steroids are widely used in various medical conditions, including rheumatoid arthritis, asthma, and inflammatory bowel disease…

Preterm Infants Facing Hemangioma Risks

A recent multicenter cohort study reveals that preterm infants are more likely to develop severe forms of infantile hemangiomas (IH), raising concerns about delayed diagnosis and potential scarring risks.

Minimally Invasive Treatment Delays Knee Surgery

Genicular artery embolization (GAE), a minimally invasive procedure, offers promising relief for patients with knee osteoarthritis, potentially delaying or eliminating the need for knee replacement surgery, according to new findings presented at the Radiological Society of North America (RSNA) annual meeting.

Pharmacy Closures Threaten Community Care Access

Independent pharmacies and those in predominantly Black and Latinx neighborhoods face a growing crisis as retail pharmacy closures surge, impacting access to care and community health.

Advances in Atopic Dermatitis and Chronic Hand Eczema

AD, also known as eczema, is a chronic condition characterized by inflammation, redness, and skin irritation, which can significantly…

AMJ Dermatology 1 [Supplement 1]

Discover the latest breakthroughs in dermatology from the 2024 Fall Clinical Dermatology Conference. This article reviews new findings on…

Thrombosis Risks Rise in ICI-Treated Lung Cancer

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Vaccine Timing Boosts Cancer Survival Rates

Patients with cancer vaccinated against COVID-19 within 6 months before infection showed significantly higher survival rates, according to a new analysis from the ASCO COVID-19 Registry.

Interview: Roy Fleischmann

There are probably two main reasons. The first is that during medical school and my post-medical school training, the most dynamic…

Remdesivir Lowers 30-Day COVID-19 Readmissions in Vulnerable Patients

A retrospective study highlighted the effectiveness of remdesivir in reducing 30-day COVID-19-related readmissions among vulnerable patient populations, including older adults and those with immunocompromising conditions.